Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreren
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. Hongkong
  4. Hong Kong Stock Exchange
  5. Genscript Biotech Corporation
  6. Nieuws
  7. Persberichten
    1548   KYG3825B1059

GENSCRIPT BIOTECH CORPORATION

(1548)
  Rapport
Vertraagde tijd Hong Kong Stock Exchange  -  09:08:49 03-02-2023
27.30 HKD   -4.21%
30/01Genscript Biotech's Fase 3 studie voor Myeloma behandeling bereikt primair eindpunt; aandelen dalen met 4%
MT
18/01GenScript ProBio, gesteund door Hillhouse, haalt $224 miljoen op bij Legend Capital en anderen
MR
03/01Chinese toezichthouder aanvaardt Genscript Biotechs nieuwe geneesmiddelenaanvraag voor chimere antigen receptor; aandelen stijgen met 6%.
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť GENSCRIPT BIOTECH CORPORATION
2022Cell and Gene Therapy Companies Leverage GenScript's cGMP sgRNA Capability to Accelerat..
PR
2022GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS
AQ
2022GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identifica..
PR
2022Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will furth..
AQ
2022GenScript Named a BioSpace 2023 Best Place to Work
PR
2022GenScript and Gladstone-UCSF Institute of Genomic Immunology Collaborate on Groundbreak..
PR
2022GenScript and Avectas Team Up to Improve the Non-Viral Cell Therapy Manufacturing Proce..
PR
2022GenScript USA Responds to Monkeypox Public-Health Emergency with Real-Time PCR Test
PR
2022GenScript Launches Expedited mRNA Service for Research and Pre-Clinical Applications
PR
2022GenScript to Host 2nd Annual Gene & Cell Engineering Virtual Summit
PR
2022GenScript USA Enters Distribution Agreement with EUROIMMUN US for cPass SARS-CoV-2 Neut..
PR
2022GenScript Debuts Industry's Highest Throughput DNA Synthesis Platform for Commercial DN..
PR
2021Genscript Biotech : Launches Closed-End Double-Stranded DNA Service for CRISPR
PU
2021GenScript Launches Closed-End Double-Stranded DNA Service for CRISPR
PR
2021Genscript Biotech : Reports First Half 2021 Results
PR
2021Genscript Biotech : Reports 2021 Interim Financial Results
PR
2021Discloseable Transactions : Deemed disposal of equity interest in probio cayman
PU
2021Genscript : to Host Gene & Cell Engineering Virtual Summit
PR
2021Genscript Biotech : Duke-NUS and GenScript Announce Notice of Allowance for U.S. Patent Ap..
PU
2021Genscript : Biotech and Ligand Pharmaceuticals Enter into Global OmniAbģ Licensing Agreeme..
PR
2021Overseas Regulatory Announcement : The entry into a subscription agreement for sale of ord..
PU
2021Genscript Biotech : Issue of new shares under general mandate
PU
2021Inside Information : Disposal of shares by a controlling shareholder
PU
2021Discloseable Transactions : (1) binding term sheet in relation to the proposed financing o..
PU
2021Genscript Biotech : Trading halt
PU
2021Genscript Biotech : Exchange notice - trading halt
PU
2021Genscript Biotech : Voluntary announcement-research and development update
PU
2021Genscript : Launches Research-Grade Lentiviral Vector Packaging Service
PR
2021Genscript Biotech : Parkway Laboratories and Diagnostics Development (DxD) Hub collaborate..
PU
2021Genscript Biotech : Overseas regulatory announcement annual report for the year ended 31 d..
PU
2021Genscript Biotech : Grant of share options and restricted shares
PU
2021Genscript Biotech : Reports Full Year 2020 Financial Results and Business Results
PR
2021Genscript Biotech : Reports Full Year 2020 Financial Results
PR
2021Genscript Biotech : receives "Best Contract Research Organization Award" IN the 4th Annual..
PU
2021Genscript : Submits Application with FDA for Use of cPass™ SARS-CoV-2 Neutralization..
PR
2020Genscript : Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutrali..
PR
2020Genscript Biotech : Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 ..
PU
2020Beroni : Announces Successful Completion of SARS-CoV-2†Pseudovirus Neutralization Assay fo..
AQ
2020Beroni Group Limited (nsx : BTG) Successful Completion of SARS-CoV-2 Assay
AQ
2020Genscript Biotech : Interim report 2020
PU
2020Genscript Biotech : Inside information and resumption of trading
PU
2020Genscript Biotech : Trading halt
PU
2020Genscript Biotech : Announcement of unaudited consolidated interim results for the six mon..
PU
2020Genscript Biotech : Cayman and GenScript Partner to Offer Neoantigen Profiling and Synthes..
AQ
2020Beroni Group Limited (nsx : BTG) Signs Agreement with Genscript Biotech
AQ
2020Genscript Biotech : Voluntary announcement-research and development update
PU
2020Genscript Biotech : List of directors and their role and function
PU
2020Genscript Biotech : Change of chief executive officer and redesignation of director
PU
2020Genscript Biotech : Announces Publication of Clinical Data On New Method for Detecting COV..
PR
2020Genscript Biotech : TRANSFER OF DISTRIBUTION ADSs AND DESPATCH OF CHEQUES FOR CASH PAYMENT..
PU
2020Genscript Biotech : Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 se..
AQ
2020Genscript Probio : and Eutilex Enter into Exclusive Strategic Collaboration on Plasmid and..
PR
2020Genscript Biotech : Proposed spin-off of legend biotech corporation
PU
2020Genscript Biotech : Donates Protective Supplies to Fight Coronavirus, Calls for Greater At..
PR
2019Genscript Biotech : Voluntary announcement - investment agreement with zhenjiang committee
PU
2019Genscript Biotech : and Selecxine Enter Into Strategic Cooperation Agreement
PR
2019Genscript Biotech : China's Largest Plasmid and Virus Facility from GenScript was Put into..
PR
2019Genscript Biotech : to Host Global Forum on Cell and Gene Therapy and the Booming China Ma..
PR
2019Genscript Biotech : Next Day Disclosure Return
PU
2019Genscript Biotech : Voluntary announcement - research and development update
PU
2019Genscript Biotech : Grant of share options and grant of restricted shares
PU
2019Genscript Biotech : Voluntary announcement - research and development update
PU
2017Genscript Biotech : Launches Custom Rabbit Monoclonal Antibody Service
PU
2016Genscript Biotech : Corporation Finishes Year with Successful Hong Kong IPO
BU
Volgende evenement op GENSCRIPT BIOTECH CORPORATION